Xin Lu publications per year

The chart shows the history of publications by Xin Lu between 1992 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Xin Lu published across 34 years, from 1992 to 2025, averaging 14.7 papers a year. Output peaked at 199 publications in 2023. 46 of the 501 publications appeared in the last two years.

No. of publications

50 100 150

1992 2025

501 publications in total across all disciplines

View publications per year as a table

Xin Lu: publications per year, 1992 to 2025
Year	Publications
1992	1
1993	2
1994	3
1995	3
1996	3
1997	4
1998	1
1999	8
2000	3
2001	2
2002	4
2003	6
2004	8
2005	8
2006	8
2007	9
2008	10
2009	3
2010	12
2011	13
2012	6
2013	12
2014	14
2015	13
2016	10
2017	10
2018	20
2019	14
2020	12
2021	12
2022	22
2023	199
2024	19
2025	27
Total	501

Download as CSV

Xin Lu publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Xin Lu sits on this spectrum.

No. of scientists

50 100 150

47–56 publications 564+

This scientist: 182 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

View publications distribution as a table

Number of Molecular Biology scientists by publication count, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
Publications	Scientists	This scientist
47–56	7
57–66	17
67–76	65
77–86	90
87–96	125
97–106	131
107–116	162
117–126	177
127–136	158
137–146	158
147–156	146
157–166	159
167–176	131
177–186	110	182
187–196	112
197–206	100
207–216	89
217–226	98
227–236	74
237–246	72
247–256	63
257–266	53
267–276	54
277–286	49
287–296	52
297–306	43
307–316	46
317–326	41
327–336	42
337–346	31
347–356	28
357–366	29
367–376	26
377–386	24
387–396	24
397–406	14
407–416	13
417–426	20
427–436	12
437–446	20
447–456	11
457–466	10
467–476	14
477–486	14
487–496	10
497–506	13
507–516	13
517–526	2
527–536	4
537–546	6
547–556	8
557–563	6
564+	100

Download as CSV

Xin Lu D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Xin Lu sits on this spectrum.

No. of scientists

25 50 75 100 125

40–41 D-Index 145+

This scientist: 80 D-Index — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

View D-Index distribution as a table

Number of Molecular Biology scientists by D-index, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
D-Index	Scientists	This scientist
40–41	36
42–43	101
44–45	115
46–47	121
48–49	118
50–51	130
52–53	106
54–55	116
56–57	113
58–59	129
60–61	120
62–63	105
64–65	131
66–67	95
68–69	97
70–71	106
72–73	83
74–75	89
76–77	77
78–79	70
80–81	73	80
82–83	60
84–85	48
86–87	45
88–89	50
90–91	31
92–93	51
94–95	43
96–97	38
98–99	39
100–101	41
102–103	29
104–105	33
106–107	35
108–109	20
110–111	38
112–113	19
114–115	28
116–117	13
118–119	23
120–121	16
122–123	15
124–125	11
126–127	21
128–129	7
130–131	13
132–133	14
134–135	17
136–137	9
138–139	8
140–141	16
142–143	7
144	7
145+	100

Download as CSV

Overview

Xin Lu is affiliated with the University of Oxford in the United Kingdom. Their research spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions in subfields such as Molecular Biology, Oncology, Surgery, Cell Biology, and Cancer Research.

The scientist has published extensively on a range of topics. Their main research areas include:

Cancer Immunotherapy and Biomarkers
Esophageal Cancer Research and Treatment
Cancer-related Molecular Pathways
RNA Modifications and Cancer
Cellular Mechanics and Interactions
Epigenetics and DNA Methylation
Cancer Cells and Metastasis

Xin Lu has contributed to a number of recent publications. Notable papers include:

"Arsenic Trioxide Rescues Structural p53 Mutations through a Cryptic Allosteric Site", 2020, published in Cancer Cell
"A deep learning framework for quality assessment and restoration in video endoscopy", 2020, published in Medical Image Analysis
"Targeted inhibition of SIRT6 via engineered exosomes impairs tumorigenesis and metastasis in prostate cancer", 2021, published in Theranostics
"Human ZBP1 induces cell death-independent inflammatory signaling via RIPK3 and RIPK1", 2022, published in EMBO Reports
"Tuning Transcription Factor Availability through Acetylation-Mediated Genomic Redistribution", 2020, published in Molecular Cell

The scientist frequently publishes in venues such as:

bioRxiv (Cold Spring Harbor Laboratory)
Cancer Research
Cell Death and Disease
SSRN Electronic Journal
Cancer Cell

Xin Lu collaborates regularly with several co-authors, including:

Richard Owen
Mark R. Middleton
Felix Zhou
Thomas Carroll
Benjamin Schuster-Böckler

Best Publications

Live or let die: the cell's response to p53

Karen H. Vousden;Xin Lu

4737
Citations
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012

Galluzzi L;Vitale I;Vitale I;Vitale I;Abrams Jm;Alnemri Es

3153
Citations
Comprehensive genomic profiles of small cell lung cancer

Julie George;Jing Shan Lim;Se Jin Jang;Yupeng Cun

2106
Citations
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

Martin Peifer;Lynnette Fernández-Cuesta;Martin L. Sos;Julie George

1542
Citations
Differential induction of transcriptionally active p53 following UV or ionizing radiation : defects in chromosome instability syndromes ?

Xin Lu;David P. Lane

1045
Citations
X chromosomal abnormalities in basal-like human breast cancer

Andrea L. Richardson;Zhigang C. Wang;Arcangela De Nicolo;Arcangela De Nicolo;Xin Lu

968
Citations
ASPP proteins specifically stimulate the apoptotic function of p53.

Yardena Samuels-Lev;Daniel J. O'Connor;Daniele Bergamaschi;Giuseppe Trigiante

934
Citations
A genomics-based classification of human lung tumors

Danila Seidel;Thomas Zander;Lukas C. Heukamp;Martin Peifer

641
Citations
p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis.

Daniele Bergamaschi;Milena Gasco;Louise Hiller;Alexandra Sullivan

576
Citations
A complex barcode underlies the heterogeneous response of p53 to stress

Fiona Murray-Zmijewski;Elizabeth A. Slee;Xin Lu

568
Citations
High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers.

Steffen Fredersdorf;Jorges Burns;Alistair M. Milne;Graham Packham

541
Citations
iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human

Daniele Bergamaschi;Yardena Samuels;Nigel J. O'Neil;Giuseppe Trigiante

524
Citations
E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction.

J K Hsieh;S Fredersdorf;T Kouzarides;K Martin

409
Citations
Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant.

S Rowan;R L Ludwig;Y Haupt;S Bates

393
Citations
To die or not to die: how does p53 decide?

Elizabeth A Slee;Daniel J O'Connor;Xin Lu

392
Citations
Functional regulation of p73 and p63: development and cancer

Gerry Melino;Xin Lu;Milena Gasco;Tim Crook

386
Citations
Residual Embryonic Cells as Precursors of a Barrett's-like Metaplasia

Xia Wang;Hong Ouyang;Yusuke Yamamoto;Pooja Ashok Kumar

375
Citations
RB Regulates the Stability and the Apoptotic Function of p53 via MDM2

Jung-Kuang Hsieh;Florence S.G Chan;Daniel J O’Connor;Sibylle Mittnacht

368
Citations
Epithelial cell polarity: a major gatekeeper against cancer?

C Royer;X Lu

344
Citations
Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo.

Alexandra Sullivan;Nelofer Syed;Milena Gasco;Daniele Bergamaschi

339
Citations

Frequent Co-Authors

Robert D. Goldin Imperial College London

Jens Rittscher University of Oxford

Gerry Melino University of Rome Tor Vergata

David P. Lane Karolinska Institute

Yardena Samuels Weizmann Institute of Science

Christopher J. Schofield University of Oxford

Hextan Y.S. Ngan University of Hong Kong

Karen H. Vousden The Francis Crick Institute

Anne H. O’Donnell-Luria Broad Institute

Ingo Helbig Children's Hospital of Philadelphia

External Links

Personal website of Xin Lu

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Exploring molecular biology opens the door to a range of rewarding careers in healthcare and research. Many students find that combining a molecular biology background with nursing or healthcare degrees enhances their job prospects and scope of practice.

For those interested in advancing their nursing careers, online bridge programs offer fast-track opportunities. If you’re looking for the 6 month rn to bsn program or want information on streamlined progression with asn to fnp programs, you’ll find solutions that work with your schedule. These programs can lead to specialized roles, including nurse practitioner positions.

Interested in mental health? Becoming a psychiatric nurse practitioner may be a strong career option. The pmhnp salary and job outlook are both attractive. If you’re wondering how long to become nurse practitioner, there are pathways that offer accelerated routes without sacrificing educational quality.

Whether you pursue molecules in the lab or transition to patient care, online degrees and bridge programs provide flexible and accessible career pathways for students of molecular biology.